Samsung to launch 2 foldable smartphones in H2 2020: Report - Seoul News
by Maria Thomas | Updated Jun 28, 2020
Samsung is projected to unveil the Galaxy Fold 2 and the 5G variant of the Galaxy Z Flip at an event in August, along with its flagship phablet Galaxy Note 20 series, Yonhap news agency reported, citing the industry sources.
But its affordable foldable smartphone, presumably named the Galaxy Fold Lite, is not likely to make its debut at the event, they said.
The South Korean tech giant has been rumoured to introduce a version of its foldable smartphone that sells for nearly half the price of a regular Galaxy Fold.
Tech reviewers have predicted that the Galaxy Fold 2 will feature a 7.7-inch screen when unfolded, while having a 6.23-inch cover display, both larger than its predecessor's 7.3-inch and 4.6-inch displays, respectively.
Samsung is expected to use ultra-thin glass (UTG) for the Galaxy Fold 2, as it did it for the Galaxy Z Flip. However, many predicted that the second generation of the Galaxy Fold is not likely to sport the S-Pen.
The 5G variant of the Galaxy Z Flip is not expected to have major changes in specifications from the first model, according to the sources.
Samsung's unveiling of the new foldable smartphones will come amid stiff competition from Huawei and Microsoft.
China's Huawei is reportedly planning to release its Mate X2, while Microsoft is looking to introduce the Surface Duo in the third quarter of the year.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report